RARA CRAFT DATABASE for FDA Medical Devices
510(k)K162858

FDA DEVICE FACTS

NITRILECARE NITRILE EXAMINATION GLOVES POWDER FREE, BLUE, CHEMOTEST

Careplus (M) Sdn Bhd

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 24, 2017PRODUCT CODELZC

Indications for use

A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or

finger to prevent contamination between patient and examiner.

These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs:

Chemotherapy Drugs Permeation The following chemicals have been tested with these gloves.

Chemotherapy Concentration Minimum Breakthrough Detection Time (min) Fluorouracil (Adrucil) 50.0mg/ml >240 Etopside(Toposar) 20.0mg/ml >240 Cyclophosphamide(Cytoxan) 20.0mg/ml >240 *Carmustine(BCNU) 3.3m¢g/ml 10,2 *Thiotepa 10.0mg/ml 40.5 Paclitaxel(Taxol) 6.0mg/m! >240 Doxorubicin Hydrochloride(Adriamycin) 2.0mg/ml _ >240 Dacarbazine 10.0mg/ml ' >240 Cisplatin 1.0mg/ml >240 Ifosfamide 50.0mg/ml >240 Mitoxantrone 2.0mg/ml >240 Vincristine Sulfate 1.0mg/ml >240

*Please note that following drugs have extremely low permeation times: Carmustine (BCNU) :10.2 minutes and Thiotepa:40.5 minutes

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 29, 2026